All Stories

  1. Left Ventricular Remodeling after Mitral Valve Surgery for Primary Mitral Regurgitation: A Bi-phasic Progression
  2. EuroEcho-Imaging 2016: highlights
  3. EuroEcho-Imaging 2015: highlights
  4. Determinants of functional capacity after mitral valve annuloplasty or replacement for ischemic mitral regurgitation
  5. Clinical Significance of Exercise Pulmonary Hypertension in Secondary Mitral Regurgitation
  6. Usefulness of Preoperative Atrial Fibrillation to Predict Outcome and Left Ventricular Dysfunction After Valve Repair for Mitral Valve Prolapse
  7. EuroEcho-Imaging 2014: highlights
  8. Tricuspid Regurgitation Is Associated With Increased Risk of Mortality in Patients With Low-Flow Low-Gradient Aortic Stenosis and Reduced Ejection Fraction
  9. E-learning in cardiovascular imaging: another step towards a structured educational approach
  10. Elevated heart rate at 24–36h after admission and in-hospital mortality in acute in non-arrhythmic heart failure
  11. Prognostic impact of global left ventricular hemodynamic afterload in severe aortic stenosis with preserved ejection fraction
  12. 0112: Determinants and prognostic impact of left ventricular contractile reserve in asymptomatic aortic stenosis
  13. 0110: Exercise stress echocardiography in secondary mitral regurgitation: impact of pulmonary hypertension
  14. Pulmonary Hypertension in Valvular Disease
  15. 0043: Prognosis of patients admitted with chest pain in emergency department and discharged with low risk of acute coronary syndrome
  16. 0111: Prognostic impact of global left ventricular hemodynamic afterload in severe aortic stenosis with preserved ejection fraction: a cardiac catheterization-based study
  17. 0227: Why patients delay their call during STEMI?
  18. 0224: Prevalence and prognostic significance of left-sided valvular thickening in patients with systemic light-chain amyloidosis
  19. 0434: Impact of low flow on long-term survival in patients with severe aortic stenosis and preserved left ventricular ejection fraction: a cardiac catheterization study
  20. Timing and Patient’s Selection for Surgical Repair of Secondary Mitral Valve Regurgitation
  21. Late gadolinium enhancement CMR in primary mitral regurgitation
  22. Restrictive mitral valve annuloplasty versus mitral valve replacement for functional ischemic mitral regurgitation: An exercise echocardiographic study
  23. Usefulness of Serial B-type Natriuretic Peptide Assessment in Asymptomatic Aortic Stenosis
  24. Platelet reactivity and cardiovascular events after percutaneous coronary intervention in patients with stable coronary artery disease: the Stent Thrombosis In Belgium (STIB) trial
  25. Reply to the Editor
  26. Determinants of exercise-induced pulmonary arterial hypertension in systemic sclerosis
  27. Faculty Opinions recommendation of Mitral-valve repair versus replacement for severe ischemic mitral regurgitation.
  28. IMPACT OF VALVULO-ARTERIAL IMPEDANCE ON LONG-TERM SURVIVAL IN PATIENTS WITH SEVERE AORTIC STENOSIS AND PRESERVED LEFT VENTRICULAR EJECTION FRACTION: A CARDIAC CATHETERIZATION STUDY
  29. Carotid Artery and Aortic Stiffness Evaluation in Aortic Stenosis
  30. Brain natriuretic peptide release in patients with aortic stenosis: Resting and exercise echocardiographic determinants
  31. Exercise Testing in Asymptomatic Severe Aortic Stenosis
  32. Assessment of left ventricular volumes and primary mitral regurgitation severity by 2D echocardiography and cardiovascular magnetic resonance
  33. Aortic Stenosis
  34. Secondary Mitral Regurgitation
  35. Faculty Opinions recommendation of Flow-gradient patterns in severe aortic stenosis with preserved ejection fraction: clinical characteristics and predictors of survival.
  36. Left Ventricular Systolic Function in Ischemic Mitral Regurgitation: Time to Look beyond Ejection Fraction
  37. The role of stress testing in evaluation of asymptomatic patients with aortic stenosis
  38. Faculty Opinions recommendation of Predictors of mortality and outcomes of therapy in low-flow severe aortic stenosis: a Placement of Aortic Transcatheter Valves (PARTNER) trial analysis.
  39. Stress Echocardiography and Mitral Valvular Heart Disease
  40. Faculty Opinions recommendation of Prognostic significance of exercise-induced right ventricular dysfunction in asymptomatic degenerative mitral regurgitation.
  41. Faculty Opinions recommendation of Association of myocardial deformation with outcome in asymptomatic aortic stenosis with normal ejection fraction.
  42. Faculty Opinions recommendation of Right ventricular systolic function in organic mitral regurgitation: impact of biventricular impairment.
  43. PROGNOSTIC VALUE OF PLASMA BRAIN NATRIURETIC PEPTIDE LEVELS RESPONSE DURING EXERCISE IN ASYMPTOMATIC PATIENTS WITH AORTIC STENOSIS
  44. Dynamic ischaemic mitral regurgitation and the role of stress echocardiography
  45. 154: Prognostic Importance of Exercise Brain Natriuretic Peptide in Asymptomatic Degenerative Mitral Regurgitation
  46. 164: Short and long-term outcome of low flow, low gradient severe aortic stenosis with preserved left ventricular ejection fraction: Results from a cardiac catheterization study
  47. 159: Preoperative atrial fibrillation predicts outcome after valve repair for mitral valve prolapse
  48. 124: Echocardiographic determinants of maximal exercise capacity in asymptomatic patients with primary mitral regurgitation
  49. Prognostic importance of exercise brain natriuretic peptide in asymptomatic degenerative mitral regurgitation
  50. The Impact of Complete Revascularization on Long-Term Survival Is Strongly Dependent on Age
  51. Stress testing for the evaluation of patients with mitral regurgitation
  52. Exercise Testing in Aortic Stenosis and in Mitral Regurgitation
  53. Reply
  54. A prospective study of cardiac valvular status in patients treated with cabergoline for endocrine disease
  55. The importance of exercise echocardiography for clinical decision making in primary mitral regurgitation
  56. Relation of mitral valve morphology and motion to mitral regurgitation severity in patients with mitral valve prolapse
  57. Clinical Outcome in Asymptomatic Severe Aortic Stenosis
  58. 173 Brain natriuretic peptide in asymptomatic degenerative mitral regurgitation: Determinants and impact on outcome
  59. 194 Clinical outcome in asymptomatic severe aortic stenosis. Insights from the new proposed aortic stenosis grading classification
  60. 132 Left ventricular contractile reserve in asymptomatic degenerative mitral regurgitation: Evaluation and impact on outcome
  61. 134 Quantitative assessment of left ventricular function by 2D-speckle tracking during exercise: A feasibility study
  62. 183 Exercise pulmonary hypertension in asymptomatic severe aortic stenosis: determinant and impact on outcome
  63. Risk Stratification in Asymptomatic Aortic Stenosis
  64. Ischemic Mitral Regurgitation: Not Only a Bystander
  65. Clinical significance of active myeloperoxidase in carotid atherosclerotic plaques
  66. Prediction of Exercise Pulmonary Hypertension in Asymptomatic Degenerative Mitral Regurgitation
  67. Chapter 14b Mitral valve disease
  68. Stress testing in valvular heart disease: clinical benefit of echocardiographic imaging
  69. 138 Brain natriuretic peptide predicts left ventricular contractile reserve in asymptomatic degenerative mitral regurgitation
  70. 139 Exercise pulmonary hypertension in asymptomatic organic mitral regurgitation
  71. Impact of Aortic Valve Stenosis on Left Atrial Phasic Function
  72. Exercise-Induced Changes in Degenerative Mitral Regurgitation
  73. Impact of Mitral Regurgitation and Myocardial Viability on Left Ventricular Reverse Remodeling After Cardiac Resynchronization Therapy in Patients With Ischemic Cardiomyopathy
  74. Sleep apnea in patients with heart failure: Could cardiac resynchronization therapy be the first line treatment?
  75. Contractile Reserve Assessed Using Dobutamine Echocardiography Predicts Left Ventricular Reverse Remodeling after Cardiac Resynchronization Therapy: Prospective Validation in Patients with Left Ventricular Dyssynchrony
  76. Prognostic Effect of Long-Axis Left Ventricular Dysfunction and B-Type Natriuretic Peptide Levels in Asymptomatic Aortic Stenosis
  77. 183 Determinants of Plasma Brain Natriuretic Peptide Release in Aortic Stenosis
  78. 154 Net Atrioventricular Compliance in Patients with Severe Aortic Stenosis
  79. 164 Degenerative Mitral Regurgitation Severity Changes During Exercise Echocardiography
  80. Usefulness and Limitation of Dobutamine Stress Echocardiography to Predict Acute Response to Cardiac Resynchronization Therapy
  81. 174 Is Left Ventricular Longitudinal Function a Determinant of Plasma Brain Natriuretic Peptide during Exercise in Patients with Organic Mitral Regurgitation?
  82. 175 Changes in Systolic Pulmonary Arterial Pressure during Exercise are Related to Changes in Mitral Regurgitation
  83. 075 Echocardiographic Determinants of Diffusing Lung Capacity in Patients with Cardiovascular Disease
  84. 117 Long-axis Dysfunction Is Related to Symptomatic Status and Brain Natriuretic Peptide Level in Aortic Stenosis
  85. 122 Is Left Ventricular Longitudinal Function Related to Metabolic Abnormalities and Fat Distribution?
  86. 124 Does Resting Left Ventricular Longitudinal Function may predict Exercise Pulmonary Hypertension in Organic Mitral Regurgitation?
  87. 167 Is Global Left Ventricular Afterload has an Impact on Left Atrial Function in Patients with Aortic Stenosis?
  88. 170 Left Ventricular Longitudinal Function is a Determinant of Plasma Brain Natriuretic Peptide in Degenerative Mitral Regurgitation
  89. A New Look to an Old Measurement⁎⁎Editorials published in the Journal of the American College of Cardiology reflect the views of the authors and do not necessarily represent the views of JACC or the American College of Cardiology.
  90. Phosphate-Dependent Regulation of MGP in Osteoblasts: Role of ERK1/2 and Fra-1
  91. Continued Global Left Ventricular Remodeling Is Not the Sole Mechanism Responsible for the Late Recurrence of Ischemic Mitral Regurgitation after Restrictive Annuloplasty
  92. Usefulness of NT-pro BNP monitoring to identify echocardiographic responders following cardiac resynchronization therapy
  93. Dysfunction of a bileaflet mechanical valve in mitral position: Absence of symptoms despite a completely fixed leaflet
  94. Prosthetic Valve Dysfunction
  95. Ischemic Mitral Regurgitation: A Complex Multifaceted Disease
  96. Restrictive Annuloplasty for Ischemic Mitral Regurgitation May Induce Functional Mitral Stenosis
  97. Prosthesis–patient mismatch after mitral valve replacement: Back to reality
  98. Direction of persistent ischemic mitral jet after restrictive valve annuloplasty: Implications for interpretation of perioperative echocardiography
  99. Safety of the cardiac triple therapy: The experience of the Quebec Heart Institute
  100. A Simple Doppler Echocardiography Method to Evaluate Pulmonary Capillary Wedge Pressure in Patients with Atrial Fibrillation
  101. Preoperative Posterior Leaflet Angle Accurately Predicts Outcome After Restrictive Mitral Valve Annuloplasty for Ischemic Mitral Regurgitation